Cargando…
Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation
OBJECTIVE: The objectives of this study were to observe the changes in follicle-stimulating hormone (FSH) and bone mineral density (BMD) in postmenopausal women, to research the relationship between FSH and postmenopausal osteoporosis, and to observe the effects of FSH on osteoclast differentiation...
Autores principales: | Wang, Jie, Zhang, Wenwen, Yu, Chunxiao, Zhang, Xu, Zhang, Haiqing, Guan, Qingbo, Zhao, Jiajun, Xu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524683/ https://www.ncbi.nlm.nih.gov/pubmed/26241313 http://dx.doi.org/10.1371/journal.pone.0134986 |
Ejemplares similares
-
Thyroid-stimulating hormone decreases the risk of osteoporosis by regulating osteoblast proliferation and differentiation
por: Deng, Tuo, et al.
Publicado: (2021) -
Associations of reproductive factors with postmenopausal follicle stimulating hormone
por: Costa, Rebecca, et al.
Publicado: (2022) -
Association of follicle stimulating hormone and serum lipid profiles in postmenopausal women
por: Xu, Zhengfen, et al.
Publicado: (2022) -
Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women
por: Wang, Ningjian, et al.
Publicado: (2015) -
Relationships between Follicle-Stimulating Hormone and Adiponectin in Postmenopausal Women
por: Huang, Wan-Yu, et al.
Publicado: (2020)